BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19874564)

  • 1. Immune hemolytic anemia due to cimetidine: the first example of a cimetidine antibody.
    Arndt PA; Garratty G; Brasfield FM; Vemuri SL; Asuncion DJ
    Transfusion; 2010 Feb; 50(2):302-7. PubMed ID: 19874564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination.
    Brain MC; Ruether B; Valentine K; Brown C; ter Keurs H
    Transfusion; 2010 Feb; 50(2):292-301. PubMed ID: 19843291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine-induced hemolytic anemia: the fallacy of clinical associations.
    Petz LD; Gitlin N; Grant K; Rodvien R; Brotman M
    J Clin Gastroenterol; 1983 Oct; 5(5):405-9. PubMed ID: 6630967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal immune haemolysis due to antibodies to individual metabolites of 5-fluorouracil.
    Yürek S; Riess H; Kreher S; Dörken B; Salama A
    Transfus Med; 2010 Aug; 20(4):265-8. PubMed ID: 20456688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe case of cefoxitin-induced immune hemolytic anemia.
    Leaf DE; Langer NB; Markowski M; Garratty G; Diuguid DL
    Acta Haematol; 2010; 124(4):197-9. PubMed ID: 21042010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells.
    Broadberry RE; Farren TW; Bevin SV; Kohler JA; Yates S; Skidmore I; Poole J; Garratty G
    Transfus Med; 2004 Feb; 14(1):53-7. PubMed ID: 15043594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime-induced immune hemolysis.
    Malloy CA; Kiss JE; Challapalli M
    J Pediatr; 2003 Jul; 143(1):130-2. PubMed ID: 12915840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic anemia due to warm autoantibodies.
    Packman CH
    Blood Rev; 2008 Jan; 22(1):17-31. PubMed ID: 17904259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemolytic anemia and thrombocytopenia induced by cimetidine: recurrence with ranitidine administration].
    Takimoto R; Mogi Y; Kura T; Niitsu Y
    Rinsho Ketsueki; 1997 Feb; 38(2):124-8. PubMed ID: 9059066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological studies of piperacillin antibodies.
    Leger RM; Arndt PA; Garratty G
    Transfusion; 2008 Nov; 48(11):2429-34. PubMed ID: 18657075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
    Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
    Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane autoantibodies in systemic lupus erythematosus: a case of autoimmune hemolytic anemia, antiphospholipid antibodies, and transient acquired activated protein C resistance.
    Staropoli JF; Van Cott EM; Makar RS
    Transfusion; 2008 Nov; 48(11):2435-41. PubMed ID: 18673345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic anemia secondary to taking cyanidanol: demonstration of the mechanism of the erythrocyte damage].
    Beris P; Beyner F; Bisetti A; Zubler R; Miescher PA
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1763-6. PubMed ID: 3798066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
    Garratty G; Postoway N; Schwellenbach J; McMahill PC
    Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.
    Johnson ST; Fueger JT; Gottschall JL
    Transfusion; 2007 Apr; 47(4):697-702. PubMed ID: 17381629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.